ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,667.56
      0.08%
      US Tech 100
      19,264.40
      0.49%
      Dow Jones
      41,985.35
      0.08%
      Brent Oil
      71.775
      0.00%
      Bitcoin
      84,173.18
      0.15%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Kyverna Therapeutics Inc (KYTX) Quote

      Kyverna Therapeutics Inc

      Kyverna Therapeutics Inc (KYTX)

      NASDAQ
      2.38
      0.11
      (4.85%)
      Closed March 22 4:00PM
      Delayed by 15 minutes
      2.375
      -0.005
      (-0.21%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      2.38
      Bid
      2.25
      Ask
      2.74
      Volume
      470,927
      2.20 Day's Range 2.455
      2.25 52 Week Range 28.05
      Market Cap
      102.748M
      Previous Close
      2.27
      Open
      2.24
      Last Trade
      2
      @
      2.38
      Last Trade Time
      Financial Volume
      $ 1,104,413
      VWAP
      2.3452
      Average Volume (3m)
      346,013
      Shares Outstanding
      43,171,612
      Dividend Yield
      -
      PE Ratio
      -1.69
      Earnings Per Share (EPS)
      -1.4
      Revenue
      -
      Net Profit
      -60.37M

      About Kyverna Therapeutics Inc

      Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin... Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin of autoimmune and inflammatory diseases. Kyverna's pipeline includes next-generation chimeric antigen receptor T-cell (CAR T) therapies in both autologous and allogeneic formats with properties well suited for use in B cell-driven autoimmune diseases. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      kyvernatx.com
      Headquarters
      Dover, Delaware, USA
      Founded
      -
      Kyverna Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker KYTX. The last closing price for Kyverna Therapeutics was $2.27. Over the last year, Kyverna Therapeutics shares have traded in a share price range of $ 2.25 to $ 28.05.

      Kyverna Therapeutics currently has 43,171,612 shares outstanding. The market capitalization of Kyverna Therapeutics is $98 million. Kyverna Therapeutics has a price to earnings ratio (PE ratio) of -1.69.

      Ask ADVFN Intelligence (AI)

      KYTX Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 24 2025
      KYTX (4.85%)

      Form 3 - Initial statement of beneficial ownership of securities
      Edgar (US Regulatory)
      January 24 2025
      KYTX (4.85%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      January 21 2025
      KYTX (4.85%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.18-7.031252.562.652.253208652.40807164CS
      4-0.5-17.36111111112.883.032.252757662.60520386CS
      12-1.55-39.44020356233.934.262.253460133.14410562CS
      26-4.03-62.87051482066.417.22.253534314.14433521CS
      52-23.32-90.739299610925.728.052.254295398.73841322CS
      156-31.87-93.051094890534.2535.012.2542972510.84491976CS
      260-31.87-93.051094890534.2535.012.2542972510.84491976CS

      KYTX - Frequently Asked Questions (FAQ)

      What is the current Kyverna Therapeutics share price?
      The current share price of Kyverna Therapeutics is $ 2.38
      How many Kyverna Therapeutics shares are in issue?
      Kyverna Therapeutics has 43,171,612 shares in issue
      What is the market cap of Kyverna Therapeutics?
      The market capitalisation of Kyverna Therapeutics is USD 98M
      What is the 1 year trading range for Kyverna Therapeutics share price?
      Kyverna Therapeutics has traded in the range of $ 2.25 to $ 28.05 during the past year
      What is the PE ratio of Kyverna Therapeutics?
      The price to earnings ratio of Kyverna Therapeutics is -1.69
      What is the reporting currency for Kyverna Therapeutics?
      Kyverna Therapeutics reports financial results in USD
      What is the latest annual profit for Kyverna Therapeutics?
      The latest annual profit of Kyverna Therapeutics is USD -60.37M
      What is the registered address of Kyverna Therapeutics?
      The registered address for Kyverna Therapeutics is 3500 S DUPONT HWY, DOVER, DELAWARE, 19901
      What is the Kyverna Therapeutics website address?
      The website address for Kyverna Therapeutics is kyvernatx.com
      Which industry sector does Kyverna Therapeutics operate in?
      Kyverna Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      SGLYSingularity Future Technology Ltd
      $ 1.6799
      (143.43%)
      		30.76M
      VVPRVivoPower International PLC
      $ 1.2899
      (52.13%)
      		62.33M
      RNAZTransCode Therapeutics Inc
      $ 1.12
      (45.45%)
      		215.3M
      GLTOGalecto Inc
      $ 6.00
      (44.93%)
      		10.71M
      XHLDTEN Holdings Inc
      $ 1.44
      (44.38%)
      		58.43M
      YHCLQR House Inc
      $ 0.40
      (-82.38%)
      		38.32M
      KZIAKazia Therapeutics Ltd
      $ 0.9759
      (-80.02%)
      		55.66k
      DMNDamon Inc
      $ 0.0373
      (-70.02%)
      		304.17M
      TCBPTC BioPharm Holdings PLC
      $ 0.5046
      (-67.23%)
      		5.9M
      SOWGSow Good Inc
      $ 1.53
      (-44.36%)
      		698.02k
      DMNDamon Inc
      $ 0.0373
      (-70.02%)
      		304.17M
      NVDANVIDIA Corporation
      $ 117.70
      (-0.70%)
      		264.42M
      RNAZTransCode Therapeutics Inc
      $ 1.12
      (45.45%)
      		216.22M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 9.03
      (10.66%)
      		175.77M
      HOLOMicroCloud Hologram Inc
      $ 1.00
      (32.36%)
      		141.98M

      Discussion

      View Full Feed
      gorbec1 gorbec1 5 minutes ago
      I’m hear

      As far as me not posting much

      No need. We finally made it pps will follow
      MCIC
      jjjjjjjj jjjjjjjj 5 minutes ago
      It is a damn if you do and damn if you don't situation. The short sellers and market makers are over shorting it. I bought from MJNA 8 times using my Wells Fargo credit card thru FedEx delivery. The company is legit. They hope to short it as low as possible and buy them back cheap. But after coup
      AMC MJNA
      uber darthium uber darthium 6 minutes ago
      NEWBauered AGAIN !

      Hopefully we see something soon with them financials. Could rocket.
      VGTL
      manibiotech manibiotech 7 minutes ago
      I mean including US companies as well
      NWBO
      HappyLibrarian HappyLibrarian 7 minutes ago
      I’m glad you’re not the CEO LC. When was the last time you started up and ran a company?


      If that is the standard to have an opinion about the performance of NWBO management then that is standard you can have - so long as you apply it to both to people with and without favorabl
      NWBO
      Zardiw Zardiw 8 minutes ago
      BirdFlu Vax Leaky per RFK JR. $BIXT Treatment: No Problem

      https://www.youtube.com/watch?v=6EOmdskTiBA

      Z
      BIXT
      manibiotech manibiotech 8 minutes ago
      Yes I have read that NWBO has currently no partnership or role in that expansion . So you are speculating about when Roswell talks about aiming towards established companies they are only talking about NWBO without any evidence whatsoever . I can as easily speculate that they are not talking about N
      NWBO
      FOFreddie FOFreddie 8 minutes ago
      Glad to see if Bryndon did not leave X - wonder if he is Premium? Wonder what the obvious reasons were that are not so important now.

      https://x.com/bryndonfisher/status/1857200340342591857
      FNMA
      Zardiw Zardiw 9 minutes ago
      BirdFlu Vax Leaky per RFK JR. $BIXT Treatment: No Problem

      https://www.youtube.com/watch?v=6EOmdskTiBA

      Z
      BIXT
      Zardiw Zardiw 10 minutes ago
      BirdFlu Vax Leaky per RFK JR. $BIXT Treatment: No Problem

      https://www.youtube.com/watch?v=6EOmdskTiBA

      Z
      BIXT
      mick mick 10 minutes ago
      QUARTERS

      Top 5 Most Sought-After U.S. State Quarter Dollar Coins Worth Big Money!

      1999 CONN. P
      https://youtu.be/SHDGthLao2c
      Lifetime Lifetime 10 minutes ago
      That is hilarious. Actually, it is pathetic.
      BIEL
      Aquahoya Aquahoya 10 minutes ago
      Hopefully we see something soon with them financials. Could rocket.
      VGTL
      upper11 upper11 10 minutes ago
      Are these guys active
      I haven’t followed in a long time
      OMID
      DanM51 DanM51 11 minutes ago
      Great X is predicting 3 Lwlg deals for the year, lol. I predict he will be wrong AGAIN.

      The gullibility of the lwlg long time longs continues to amaze--Just because a lwlg ceo says that potential customers now don't see us as a competitor/rival, DOESN'T MAKE IT SO. Maybe they're thin
      LWLG
      lodas lodas 12 minutes ago
      It has been posted many times in filings that JPM "wrote down the assets it received to NEGATIVE EQUITY"!!!!!!!!!!!!... It was also said by JPM that they "found 30 billion dollars in commercial mortgages in the rubble of WAMU"!!!!!!!!!!!!!!.....It was also revealed that JPM "lost 14 billion dollars
      JPM
      Peter J Peter J 13 minutes ago
      My advice, badog

      You should listen to fung derf:


      OK, the more you post, the more you make it clear you don't comprehend what is happening..

      😆

      He has over a 100.000 posts... listening to himself... 🤣

      h
      ERHE
      uber darthium uber darthium 13 minutes ago
      If Michery sold his breastmilk would he not then call it “Mullen Milk” ?

      Remember when “man boobs” was on Fox Business and he said his ear monitor wasn’t functioning right after he was asked about his salary and stock options ?

      That was a funny man boob day
      MULN
      Panzer Panzer 13 minutes ago
      Reg A can be done before or in tandem with 15c211 and guaranteed Burgauer knows what to do. 
      RITE
      Zadie420 Zadie420 14 minutes ago
      Sorry I have to disagree with you I think the cost around $100k is more logical. The cost of treatment plus profit plus cost of recouping the investment in last 20 years like Flaskworks. Once this accomplished I can see they drop it down below $100k
      NWBO
      Dallas-Cowboys Dallas-Cowboys 14 minutes ago
      Cramer had Jensen and Chuck Robbin's (Cisco CEO) on Mad Money the other day. You could tell both ceos have a lot of respect for each other and they need each other to further AI in the enterprise. Jensen called Chuck around 14 months ago and as we know they have announced products over the past mont
      NVDA
      DiscoverGold DiscoverGold 14 minutes ago
      Gold & the Pullback
      By: Marty Armstrong | March 22, 2025

      standard.socratesplatform.com/Blog/GetImage/67decd1a8415d7a0af84c5ef

      QUESTION: Marty, As we head into the Silver Benchmark Next week and the Arrays warn of March as a turning point, does this suggest w
      GOLD
      blackhawks blackhawks 15 minutes ago
      Jeopardy:

      WV, MS and AR

      What are three states that will suffer greatly from a weakened FEMA?

      "I say you don't need FEMA, you need a good state government," Trump said
      USVIHI22 USVIHI22 15 minutes ago
      "Sidelined but monitoring." - Same
      ICON
      misterfishman misterfishman 16 minutes ago
      They could do a massive stroke buy back.
      ASII

      Your Recent History

      NASDAQ
      KYTX
      Kyverna Therapeutics
      USOTC
      AMNGL
      American National (PK)
      AMEX
      ITA
      iShares US Aerospace and...
      USOTC
      AMGDF
      Aston Martin Lago (PK)
      USOTC
      RGPCF
      Ratch Group Public (PK)
      AMEX
      YLD
      Principal Active High Yi...
      USOTC
      TTEVF
      Tietoevry Oyj (PK)
      USOTC
      ALSCF
      Alset AI Ventures (PK)
      AMEX
      VHT
      Vanguard Health Care ETF
      BOV
      BRKM3
      BRASKEM ON
      USOTC
      RESCU
      Rescap Liquidation (CE)
      AMEX
      IVRS
      iShares Future Metaverse...
      AMEX
      SPXV
      ProShares S&P 500 Ex Hea...
      AMEX
      ICLO
      Invesco AAA CLO Floating...
      NASDAQ
      SLXNW
      Silexion Therapeutics
      NYSE
      ASPL
      Aspirational Consumer Li...
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads